Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 7, 2014; 20(21): 6515-6522
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6515
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6515
Figure 2 miR-132 predicts disease-free survival in colorectal cancer patients.
The Kaplan-Meier curve of disease-free survival in patients with high miR-132 expression (n = 31) and low miR-132 expression (n = 31) (P < 0.01).
-
Citation: Zheng YB, Luo HP, Shi Q, Hao ZN, Ding Y, Wang QS, Li SB, Xiao GC, Tong SL. miR-132 inhibits colorectal cancer invasion and metastasis
via directly targeting ZEB2. World J Gastroenterol 2014; 20(21): 6515-6522 - URL: https://www.wjgnet.com/1007-9327/full/v20/i21/6515.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i21.6515